Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
Nature1999Vol. 401(6750), pp. 282–286
Citations Over TimeTop 1% of 1999 papers
Robert S. Ames, Henry M. Sarau, Johathan K. Chambers, Robert N. Willette, Nambi Aiyar, Anne M. Romanic, Calvert Louden, James J. Foley, Charles F. Sauermelch, Robert W. Coatney, Zhaohui Ao, Jyoti Disa, Stephen D. Holmes, Jeffrey M. Stadel, John D. Martin, Wu‐Schyong Liu, George I. Glover, Shelagh Wilson, Dean E. McNulty, Catherine Ellis, Nabil A. Elshourbagy, Usman Shabon, John J. Trill, Douglas W.P. Hay, Eliot H. Ohlstein, Derk J. Bergsma, Stephen A. Douglas
Related Papers
- → Stressin1-A, a Potent Corticotropin Releasing Factor Receptor 1 (CRF1)-Selective Peptide Agonist(2007)42 cited
- → Discovery of the First Nonpeptide Agonist of the GPR14/Urotensin-II Receptor: 3-(4-Chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954)(2002)66 cited
- → Use of N-ethylmaleimide to directly determine the proportion of β-adrenergic receptors exhibiting high affinity for agonists on human mononuclear leukocyte membranes(1989)1 cited
- → The Importence of Urotensin and Urotensin Receptors in Cardiovascular System(2014)
- Nonhemodynamic effect of urotensin-IIand its significance in some diseases(2007)